News for PharmAust Limited (PAA.AX)

PharmAust (ASX: PAA) has requested the European Medicines Agency (EMA) grant orphan medicinal product designation (OMPD) for monepantel (MPL), its lead

Organisers are forecasting strong investor turnout at a unique event featuring ASX-listed companies in Singapore later this month. Staged at the

PharmAust (ASX: PAA) has received promising interim results from a major study into monepantel (MPL), its lead amyotrophic lateral sclerosis (ALS) / motor

The three months to end June marked a transformative quarter in PharmAust’s (ASX: PAA) focus on monepantel (MPL) for the treatment of neurodegenerative

PharmAust (ASX: PAA) has raised $7.8 million in a share purchase plan (SPP) to accelerate development of its lead candidate monepantel as a viable

PharmAust’s (ASX: PAA) lead amyotrophic lateral sclerosis (ALS)/motor neurone disease (MND) treatment candidate monepantel (MPL) has been selected for

Clinical-stage biotechnology company PharmAust (ASX: PAA) has been granted small and medium-sized enterprise (SME) status by the European Medicines Agency

Clinical-stage biotechnology company PharmAust (ASX: PAA) has received strong market support for plans to progress its monepantel (MPL) neurodegenerative

The success of PharmAust's (ASX: PAA) Phase 1 MEND study into the treatment of motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) is being

Clinical-stage biotechnology company PharmAust (ASX: PAA) has appointed US-based Dr Katie MacFarlane as a non-executive director to the board. Dr

The ASX200 is trading up around 0.55% With strong performances from major…

The ASX200 closed .4 of a per cent up with IT and Health Care the locomotives of a sluggish steam energy labouring under the weight of Energy and Industrials.

The ASX200 is trading up around half a per cent with Health Care and Real Estate leading gains, up around 1.1 per cent. and Industrials falling the heaviest, down just over half a per cent.

The ASX200 closed the day up about .7 of a per cent. Most sectors finished in the green, led by materials, up 1.5 per cent.

The ASX is poised to open modestly lower on Wednesday as US indexes fell in New York. Paypal plunged 13% after cutting its margins forecast.

The US FDA will be coming to inspect Cyclopharm’s facility in Kingsgrove, New South Wales, between 24 July through 4 August.

Treasurer Jim Chalmers has forecast a modest surplus of about $4 billion in tonight’s Budget, the first surplus in 15 years.

Tesla shares were sold after Elon Musk told analysts in an earnings call yesterday that he will keep cutting prices.

On Friday, major indexes on Wall Street fell as the earnings season started. Bank stocks rallied as JPMorgan Chase comfortably beat earnings.